These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9001791)

  • 1. Management of patients with intrauterine fetal death.
    Visentin L; Leo L; Alemanno MG; Arduino S; Bellino R; Tessarolo M; Wierdis T; Lanza A
    Clin Exp Obstet Gynecol; 1996; 23(4):263-7. PubMed ID: 9001791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Use of misoprostol for induction of labor in case of fetal death or termination of pregnancy during second or third trimester of pregnancy: Efficiency, dosage, route of administration, side effects, use in case of uterine scar].
    Clouqueur E; Coulon C; Vaast P; Chauvet A; Deruelle P; Subtil D; Houfflin-Debarge V
    J Gynecol Obstet Biol Reprod (Paris); 2014 Feb; 43(2):146-61. PubMed ID: 24461423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin E2 induction of abortion and fetal demise.
    Wiley TL; Poole CP; Gookin KS; Wiser WL; Morrison JC
    Int J Gynaecol Obstet; 1989 Feb; 28(2):171-5. PubMed ID: 2563705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cesarean section on request at 39 weeks: impact on shoulder dystocia, fetal trauma, neonatal encephalopathy, and intrauterine fetal demise.
    Hankins GD; Clark SM; Munn MB
    Semin Perinatol; 2006 Oct; 30(5):276-87. PubMed ID: 17011400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of delivery by mifepristone and misoprostol in termination of pregnancy and intrauterine fetal death: 2nd and 3rd trimester induction of labour.
    Stibbe KJ; de Weerd S
    Arch Gynecol Obstet; 2012 Sep; 286(3):795-6. PubMed ID: 22434057
    [No Abstract]   [Full Text] [Related]  

  • 6. Extraamniotic prostaglandin F2 alpha for intrauterine death and fetal abnormality.
    Luengo J; Keirse MJ; Bennebroek Gravenhorst J
    Eur J Obstet Gynecol Reprod Biol; 1977; 7(5):325-9. PubMed ID: 299460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of hemorrhage during surgical evacuation for second-trimester intrauterine fetal demise.
    Fontenot Ferriss AN; Weisenthal L; Sheeder J; Teal SB; Tocce K
    Contraception; 2016 Nov; 94(5):496-498. PubMed ID: 27343749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of intrauterine fetal demise--a hospital-based study in Taiwan over a decade.
    Liu LC; Huang HB; Yu MH; Su HY
    Taiwan J Obstet Gynecol; 2013 Dec; 52(4):546-50. PubMed ID: 24411041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second-trimester abortion for fetal anomalies or fetal death: labor induction compared with dilation and evacuation.
    Boyle J; Eerden PV; McNamara M
    Obstet Gynecol; 2011 Aug; 118(2 Pt 1):362-363. PubMed ID: 21775865
    [No Abstract]   [Full Text] [Related]  

  • 10. Abortion, health, and the law.
    Marchetti P
    N Engl J Med; 2004 Apr; 350(18):1908-10; author reply 1908-10. PubMed ID: 15122814
    [No Abstract]   [Full Text] [Related]  

  • 11. Intra/extra-amniotic administration of prostaglandin F2a in fetal death, missed and therapeutic abortions.
    Salamalekis E; Kassanos D; Hassiakos D; Chrelias C; Ghristodoulakos G
    Clin Exp Obstet Gynecol; 1990; 17(1):17-21. PubMed ID: 2194705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of 15-methylated derivative of prostaglandin F2a for the therapeutic termination of pregnancy and management of late fetal death.
    Antsaklis A; Politis J; Diacomanolis E; Aravantinos D; Kaskarelis D
    Int Surg; 1984; 69(1):63-8. PubMed ID: 6735634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second-trimester abortion for fetal anomalies or fetal death: a comparison of techniques.
    Westhoff C
    Obstet Gynecol; 2011 Apr; 117(4):775-776. PubMed ID: 21422846
    [No Abstract]   [Full Text] [Related]  

  • 14. [Periovular: valid method for no viable pregnancy in the 1st-2nd trimester].
    Mondión M; Henríquez R; Silva S; González F; Insunza A; Vargas JE; Paiva E; Hernández JP
    Rev Chil Obstet Ginecol; 1994; 59(3):177-80. PubMed ID: 7659808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Termination of normal and pathological pregnancy with Sulprostone.
    Fischer Z; Chwalisz K; Michałkiewicz W
    Acta Chir Hung; 1986; 27(3):151-6. PubMed ID: 3825407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Misoprostol in second and early third trimester for termination of pregnancies with fetal anomalies.
    Mendilcioglu I; Simsek M; Seker PE; Erbay O; Zorlu CG; Trak B
    Int J Gynaecol Obstet; 2002 Nov; 79(2):131-5. PubMed ID: 12427397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demographic, Clinical, and Counseling Factors Associated with the Selection of Pregnancy Termination Method in the Second Trimester for Fetal and Pregnancy Anomalies.
    Maistrellis E; Janiak E; Hammel R; Hurwitz S; Delli-Bovi L; Bartz D
    Womens Health Issues; 2019; 29(4):349-355. PubMed ID: 31085003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Success rate of cytogenetic analysis at the time of second-trimester dilation and evacuation.
    Bernick BA; Ufberg DD; Nemiroff R; Donnenfeld A; Tolosa JE
    Am J Obstet Gynecol; 1998 Oct; 179(4):957-61. PubMed ID: 9790378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Labor induction in intrauterine fetal death].
    Butterwegge M; Gethmann U; Ohlenroth G
    Zentralbl Gynakol; 1990; 112(21):1335-9. PubMed ID: 2278217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose sulprostone for pregnancy termination in cases of fetal abnormality.
    Kanhai HH; Keirse MJ
    Prenat Diagn; 1993 Feb; 13(2):117-21. PubMed ID: 8464832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.